Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of α1-noradrenergic receptors demonstrated by in vivo voltammetry
- 1 September 1988
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 460 (2) , 398-401
- https://doi.org/10.1016/0006-8993(88)90390-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivoNeuroscience Letters, 1987
- Application of in Vivo Electrochemistry to Cholecystokinin-Dopamine Interactions in the Ventral StriatumPublished by Springer Nature ,1987
- Electrochemistry in Vivo: Application to CNS PharmacologyaAnnals of the New York Academy of Sciences, 1986
- In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbensBrain Research, 1986
- Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neuronsJournal of Neuroscience, 1985
- Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiologyBrain Research, 1985
- Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neuronsJournal of Neuroscience, 1983
- Chemically modified electrode for in vivo monitoring of brain catecholaminesBrain Research Bulletin, 1983
- Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activityLife Sciences, 1978
- Amantadine versus trihexyphenidyl in the treatment of neuroleptic- induced parkinsonismAmerican Journal of Psychiatry, 1976